Glycemic Control Is Associated with Histological Findings of Nonalcoholic Fatty Liver Disease
Teruki Miyake,Shinya Furukawa,Bunzo Matsuura,Osamu Yoshida,Masumi Miyazaki,Akihito Shiomi,Ayumi Kanamoto,Hironobu Nakaguchi,Yoshiko Nakamura,Yusuke Imai,Mitsuhito Koizumi,Takao Watanabe,Yasunori Yamamoto,Yohei Koizumi,Yoshio Tokumoto,Masashi Hirooka,Teru Kumagi,Eiji Takesita,Yoshio Ikeda,Masanori Abe,Yoichi Hiasa
DOI: https://doi.org/10.4093/dmj.2023.0200
2024-02-05
Diabetes & Metabolism Journal
Abstract:1 Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Toon, Japan 2 Health Services Center, Ehime University, Matsuyama, Japan 3 Department of Lifestyle-related Medicine and Endocrinology, Ehime University Graduate School of Medicine, Toon, Japan 4 Postgraduate Medical Education Center, Ehime University Graduate School of Medicine, Toon, Japan Copyright © 2024 Korean Diabetes Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Download PDF CONFLICTS OF INTEREST No potential conflict of interest relevant to this article was reported. AUTHOR CONTRIBUTIONS Conception or design: T.M., S.F., B.M., Y.H. Acquisition, analysis, or interpretation of data: T.M., S.F., O.Y., M.M., A.S., A.K., H.N., Y.N., Y.I., M.K., T.W., Y.Y., Y.K., Y.T., M.H., T.K., E.T., Y.I., M.A., Y.H. Drafting the work or revising: T.M. Final approval of the manuscript: all authors. FUNDING This research was funded by Japan Society for the Promotion of Science Kakenhi (JSPS KAKENHI), Grant Number 22K11804. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Values are presented as median (interquartile range) or percentage. To evaluate between-group differences, the Steel-Dwass test or a Tukey's test was used for continuous variables, b Chi-square test was used for categorical variables. P <0.05 was considered significant, c Duration of diabetes in patients with DM. HbA1c, glycosylated hemoglobin; NAFLD, nonalcoholic fatty liver disease; BMI, body mass index; ALT, alanine aminotransferase; UA, uric acid; TC, total cholesterol; TG, triglyceride; DM, diabetes mellitus; NAS, activity score; DPP4i, dipeptidyl peptidase-4 inhibitor; AGI, alpha-glucosidase inhibitor; GLP-1RA, glucagon-like peptide-1 receptor agonist; SGLT2i, sodium-glucose transport protein 2 inhibitor. Differences were considered statistically significant at P <0.05. Model 1 was adjusted for age (years), sex, and hemoglobin (g/L), alanine aminotransferase (IU/L), and creatinine (μmol/L) levels. Model 2 was adjusted for body mass index (kg/m 2 ) and uric acid (μmol/L), total cholesterol (mmol/L), and triglyceride (mmol/L) levels. HbA1c, glycosylated hemoglobin; OR, odds ratio; CI, confidence interval. Differences were considered statistically significant at P <0.05. Model 1 was adjusted for age (years), sex, and hemoglobin (g/L), alanine aminotransferase (U/L), and creatinine (μmol/L) levels. Model 2 was adjusted for body mass index (kg/m 2 ) and uric acid (μmol/L), total cholesterol (mmol/L), and triglyceride (mmol/L) levels. HbA1c, glycosylated hemoglobin; NAS, NAFLD activity score; OR, odds ratio; CI, confidence interval. Values are presented as median (interquartile range). To evaluate between-group differences, the Mann-Whitney U test was used for continuous variables. P <0.05 was considered significant. HOMA-IR, homeostasis model assessment of insulin resistance; NAS, NAFLD activity score.
endocrinology & metabolism